Tirzepatide

Description

Tirzepatide is a dual GIP and GLP-1 receptor agonist and the most common comparator to Semaglutide in incretin research. It is stocked across a wide range of vial strengths so a protocol can be matched without over-diluting.

Research context

• Dual GIP/GLP-1 receptor signalling
• Head-to-head incretin comparisons
• Glucose and metabolic homeostasis models

Handling and storage

Store the lyophilized vial cold; reconstituted solution should be refrigerated and used within a short working window.

Common questions

How does Tirzepatide differ from Semaglutide?

It acts on two receptors – GIP as well as GLP-1 – where Semaglutide acts on GLP-1 alone. That difference is the basis of most comparative studies.

Supplied for laboratory research use only. Not for human or veterinary use.